European Medical Solutions (STU:AS00) EPS (Basic): €0.44 (TTM As of Dec. 2025)


STU:AS00 European Medical Solutions STU:AS00
45 GF Score
Price €4.74
GF Value €8.10
! 2 Warning Signs
View Full Analysis

What is European Medical Solutions EPS (Basic)?

European Medical Solutions STU:AS00 +0.42% 45 EPS (Basic) is €0.44 as of Dec. 2025. GuruFocus rates STU:AS00 with a GF Score™ of 45/100 and a GF Value™ of €8.10. The stock has 2 warning signs investors should review.

European Medical Solutions's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was €0.20. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.44.

European Medical Solutions's EPS (Diluted) for the six months ended in Dec. 2025 was €0.20. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.44.

European Medical Solutions's EPS without NRI for the six months ended in Dec. 2025 was €0.20. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 0.44.

During the past 12 months, European Medical Solutions's average EPS without NRIGrowth Rate was 237.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, European Medical Solutions's highest 3-Year average EPS without NRI Growth Rate was 88.00% per year. The lowest was -59.20% per year. And the median was 36.85% per year.

European Medical Solutions  (STU:AS00) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

European Medical Solutions EPS (Basic) Related Terms

European Medical Solutions EPS (Basic) Historical Data

* Premium members only.

The historical data trend for European Medical Solutions's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

European Medical Solutions EPS (Basic) Chart

European Medical Solutions Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.52 -1.30 -0.18 0.13 0.44

European Medical Solutions Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.35 0.07 0.06 0.23 0.20
STU:AS00
45GF Score
European Medical Solutions STU:AS00
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

European Medical Solutions EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

European Medical Solutions's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(1.84-0)/4.232
=0.43

European Medical Solutions's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(0.851-0)/4.232
=0.20

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of €0.44 mean?
European Medical Solutions (STU:AS00) has a EPS (Basic) of €0.44 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on European Medical Solutions and its competitors.
Is European Medical Solutions' EPS (Basic) too high?
European Medical Solutions' current EPS (Basic) is €0.44. Overall, European Medical Solutions has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does European Medical Solutions' EPS (Basic) compare to VRTX and REGN?
European Medical Solutions' EPS (Basic) of €0.44 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on European Medical Solutions and its competitors. European Medical Solutions's current EPS (Basic) is €0.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is European Medical Solutions stock overvalued right now?
European Medical Solutions (STU:AS00) has a current EPS (Basic) of €0.44. The stock's GF Value™ is €8.10, compared to a current price of €4.74 — trading 41.5% below its estimated fair value. The current EPS (Basic) is €0.44. European Medical Solutions' overall GF Score™ is 45/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For European Medical Solutions (STU:AS00), the current EPS (Basic) is €0.44 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is European Medical Solutions (STU:AS00) Overvalued in 2026?

Based on GuruFocus' analysis, European Medical Solutions stock appears to be undervalued. The current stock price of €4.74 is trading 41.5% below its estimated GF Value™ of €8.10.

Key valuation signals for STU:AS00:

  • EPS (Basic): €0.44
  • GF Value™: €8.10 vs. price of €4.74 (41.5% below fair value)
  • GF Score™: 45/100 with 2 warning signs

No single metric tells the full story. See the STU:AS00 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

European Medical Solutions Business Description

Other Exchanges ALEMS:Belgium
Address 7 Rue des Chasseurs Ardennais, Liege, BEL, 4031
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
45GF Score

Get the complete analysis for STU:AS00

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.74
Price
€8.10
GF Value